<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.6.3"?>
<!-- generated-on="2026-08-02T23:17:11+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.6.3" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://slice42.com/spotlighting-dyadic-international-as-a-high-upside-biotech-opportunity/</loc><news:news><news:publication><news:name>Slice 42</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-08-02T20:01:36+00:00</news:publication_date><news:title>Spotlighting Dyadic International As A High-Upside Biotech Opportunity</news:title></news:news></url>
<url><loc>https://slice42.com/london-and-las-vegas-must-operate-as-one-trading-continuity/</loc><news:news><news:publication><news:name>Slice 42</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-08-02T15:03:36+00:00</news:publication_date><news:title>London and Las Vegas Must Operate as One Trading Continuity</news:title></news:news></url>
<url><loc>https://slice42.com/assessing-the-growth-potential-and-speculative-profile-of-dyadic-international/</loc><news:news><news:publication><news:name>Slice 42</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-08-02T15:01:38+00:00</news:publication_date><news:title>Assessing the Growth Potential and Speculative Profile of Dyadic International</news:title></news:news></url>
<url><loc>https://slice42.com/uncovering-potential-value-in-dyadic-internationals-proprietary-biotech-platform/</loc><news:news><news:publication><news:name>Slice 42</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-08-02T10:01:22+00:00</news:publication_date><news:title>Uncovering Potential Value in Dyadic International’s Proprietary Biotech Platform</news:title></news:news></url>
<url><loc>https://slice42.com/a-closer-look-at-dyadic-internationals-market-position-and-proprietary-technology/</loc><news:news><news:publication><news:name>Slice 42</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-08-02T05:00:54+00:00</news:publication_date><news:title>A Closer Look at Dyadic International’s Market Position and Proprietary Technology</news:title></news:news></url>
<url><loc>https://slice42.com/navigating-the-speculative-horizon-of-dyadic-internationals-biotech-assets/</loc><news:news><news:publication><news:name>Slice 42</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-08-02T00:01:34+00:00</news:publication_date><news:title>Navigating the Speculative Horizon of Dyadic International’s Biotech Assets</news:title></news:news></url>
<url><loc>https://slice42.com/ferdinands-trading-comeback-is-about-identity-not-nostalgia/</loc><news:news><news:publication><news:name>Slice 42</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-08-01T19:03:59+00:00</news:publication_date><news:title>Ferdinand’s Trading Comeback Is About Identity, Not Nostalgia</news:title></news:news></url>
<url><loc>https://slice42.com/unpacking-the-investment-case-for-dyadic-internationals-proprietary-biotech-platform/</loc><news:news><news:publication><news:name>Slice 42</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-08-01T19:01:46+00:00</news:publication_date><news:title>Unpacking the Investment Case for Dyadic International’s Proprietary Biotech Platform</news:title></news:news></url>
<url><loc>https://slice42.com/a-fresh-look-at-dyadic-international-and-its-niche-biotech-asset-base/</loc><news:news><news:publication><news:name>Slice 42</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-08-01T14:01:35+00:00</news:publication_date><news:title>A Fresh Look at Dyadic International and Its Niche Biotech Asset Base</news:title></news:news></url>
<url><loc>https://slice42.com/examining-dyadic-international-nasdaqdyai-through-a-high-risk-high-reward-lens/</loc><news:news><news:publication><news:name>Slice 42</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-08-01T09:01:28+00:00</news:publication_date><news:title>Examining Dyadic International (NASDAQ:DYAI) Through a High-Risk, High-Reward Lens</news:title></news:news></url>
<url><loc>https://slice42.com/why-most-new-funding-brokers-get-quietly-flagged-within-their-first-six-months/</loc><news:news><news:publication><news:name>Slice 42</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-08-01T05:02:28+00:00</news:publication_date><news:title>Why most new funding brokers get quietly flagged within their first six months</news:title></news:news></url>
<url><loc>https://slice42.com/in-alternative-business-funding-bank-deposits-now-matter-more-than-credit-scores/</loc><news:news><news:publication><news:name>Slice 42</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-08-01T05:02:16+00:00</news:publication_date><news:title>In alternative business funding, bank deposits now matter more than credit scores</news:title></news:news></url>
<url><loc>https://slice42.com/assessing-the-long-term-prospects-of-dyadic-international-nasdaqdyai/</loc><news:news><news:publication><news:name>Slice 42</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-08-01T04:01:31+00:00</news:publication_date><news:title>Assessing the Long-Term Prospects of Dyadic International (NASDAQ:DYAI)</news:title></news:news></url>
</urlset>
